This inventor holds 1 USPTO granted patent. Top assignees: Bio-Rad Innovations, Centre Hospitalier Universitaire De Lille, Université Lille 2 - Droit Et Santé. Active years: 2017.
Company Filing History:
1 out of 30 
1 out of 3 
1 out of 6 Years Active: 2017
Title: Sebastien Damiens: Innovator in Medical Diagnostics
Introduction
Sebastien Damiens is a notable inventor based in Lille, France. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of invasive candidiasis. His innovative approach has the potential to improve patient outcomes through early detection and tailored treatment.
Latest Patents
Sebastien Damiens holds 1 patent related to an in vitro method for diagnosing invasive candidiasis. This method involves detecting the presence of aglycan and antibodies against specific proteins, including fructose bisphosphate aldolase, enolase 1, heat shock protein 90, hyphal wall protein, and mannoprotein 65 in blood, plasma, or serum samples. The invention also encompasses a method for determining suitable treatment regimens and includes a kit for implementing these diagnostic methods.
Career Highlights
Throughout his career, Damiens has worked with reputable organizations such as Bio-Rad Innovations and the Centre Hospitalier Universitaire De Lille. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.
Collaborations
Sebastien Damiens has collaborated with notable professionals in his field, including Daniel Poulain and Marc Charles Victor Tabouret. These collaborations have likely contributed to the advancement of his research and inventions.
Conclusion
Sebastien Damiens is a distinguished inventor whose work in medical diagnostics has the potential to significantly impact patient care. His innovative methods for diagnosing invasive candidiasis demonstrate his commitment to advancing healthcare technology.